More than 80% of patients with myelodysplastic syndrome with ring sideroblasts (MDS-RS) carry mutations in the SF3B1 gene; during bone marrow transplantation, SF3B1-mutated MDS-RS HSCs differentiate into characteristic ring sideroblasts [18]. Here, SF3B1 is linked to myelodysplastic syndrome.